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Cardiac taurine and principal amino acids in right
and left ventricles of patients with either aortic
valve stenosis or coronary artery disease: the
importance of diabetes and gender
Martin Lewis1, Ben Littlejohns1, Hua Lin1, Gianni D Angelini1 and M-Saadeh Suleiman1,2*
Abstract
Free intracellular taurine and principal α-amino acids (glutamate, glutamine, aspartate, asparagine and alanine) are
abundant in human heart. They are cellular regulators and their concentration can change in response to disease and
cardiac insults and have been shown to differ between hypertrophic left ventricle (LV) and the relatively “normal” right
ventricle (RV) in patients with aortic valve stenosis (AVS). This difference has not been shown for coronary artery disease
(CAD) and there are no studies that have simultaneously compared amino acid content in LV and RV from different
pathologies. In this study we investigated the effect of disease on taurine and principal amino acids in both LV and RV,
measured in myocardial biopsies collected from patients with either AVS (n = 22) or CAD (n = 36). Amino acids
were extracted and measured using HPLC. Intra- and inter-group analysis was performed as well as subgroup analysis
focusing on gender in AVS and type 2 diabetes in CAD. LV of both groups has significantly higher levels of taurine
compared to RV. This difference disappears in both diabetic CAD patients and in male AVS patients. Alanine was the
only α-amino acid to be altered by diabetes. LV of female AVS patients had significantly more glutamate, aspartate and
asparagine than corresponding RV, whilst no difference was seen between LV and RV in males. LV of females has
higher glutamate and glutamine and less metabolic stress than LV of males. This work shows that in contrast to LV, RV
responds differently to disease which can be modulated by gender and diabetes.
Keywords: Left and right ventricle; Aortic valve stenosis; Coronary artery disease; Hypertrophy; Taurine; Glutamine;
Glutamate; Alanine
Introduction
Cardioprotective strategies against ischemia and reperfu-
sion are aimed at preserving intracellular metabolites and
opposing disruption to ionic homeostasis. Evaluation of
the efficacy of cardioplegic solutions during open heart
surgery has relied upon monitoring intracellular changes
of key metabolites including amino acids (Caputo et al.
1998a, b; Suleiman et al. 2001, 2008; Venturini et al.
2009). During cardioplegic arrest, the heart is rendered is-
chemic and therefore vulnerable to reperfusion injury
caused by Ca2+ loading and generation of reactive oxygen
species (Suleiman et al. 2008). Ca2+ loading occurs as a
consequence of ischemia-induced Na+ accumulation. In
addition, Na+ accumulation contributes to osmotic-
induced cell swelling, which has been implicated as a cause
of ischemia-induced sarcolemmal damage (Garcia-Dorado
and Oliveras 1993; Ruiz-Meana et al. 1995; Tritto et al.
1998). In response to cardiac insults/osmotic stress, heart
cells release free amino acids including the non-protein
β-amino acid taurine (Schaffer et al. 2002; Suleiman and
Chapman 1993a, b; Suleiman et al. 1993). Taurine is the
main organic osmolyte in the heart (Huxtable 1993) and
its trans-sarcolemmal fluxes are dependent on the Na+ gra-
dient (Suleiman et al. 1992). Our work and those of others
has shown that the fall in tissue taurine is due to efflux as
it is detected in the effluent of hearts artificially perfused
ex vivo (Suleiman et al. 1992). This is consistent with tau-
rine being very slowly metabolized and the finding that its
concentration is raised in the blood of patients following
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acute myocardial infarction, unstable angina, and cardiovas-
cular surgery (Cooper and Lombardini 1981; Lombardini
and Bricker 1981; Lombardini and Cooper 1981). This close
link between ischemic cardioplegic stress and taurine has
been supported by our work involving patients undergoing
open heart surgery (Ascione et al. 1998; Caputo et al.
1998a, b; Lotto et al. 2003; Suleiman et al. 1993, 1997)
where we have demonstrated that the higher the metabolic
stress, the greater the fall of myocardial taurine during re-
perfusion. Extensive studies have been carried out establish-
ing a link between taurine and type 2 diabetes largely in the
context of using taurine as an additive, monitoring tau-
rine plasma levels and depleting or replacing taurine with
an array of compounds (e.g. Das et al. 2012; Gossai and
Lau-Cam 2009; Tappia et al. 2011, 2013). The majority of
studies suggest beneficial effects of exogenous taurine in
protecting the diabetic cardiomyopathic heart as diabetic
patients have lower plasma taurine levels (Franconi et al.
1995, 2004). Whether lower plasma taurine reflects an in-
creased uptake by diabetic ventricle(s) is not presently
known.
In addition to taurine, the principal free α-amino acids
glutamine, glutamate, aspartate and alanine also change
in heart cells during cardiac insults in both experimental
models and during open heart surgery (Suleiman and
Chapman 1993b; Suleiman et al. 1993, 1997). However,
unlike taurine the changes in these amino acids involve
metabolism and transport and influence the biosynthesis
of several key compounds including energy rich phos-
phates (Rennie et al. 2001). The extent of the changes in
cardiac amino acids during ischemia and reperfusion de-
pends on their basal level which is determined both by
disease state and whether the tissue comes from LV or
RV. For example in hearts with aortic valve stenosis, pres-
sure overload triggers structural, functional and metabolic
remodeling in the LV (Petrov et al. 2010). In contrast and
in the early stages of the disease, the RV is not affected by
these compensatory mechanisms, as it is not chronically
overloaded. As a result, the cardiac pump is likely to end
up having two ventricles with different metabolic states.
Left ventricular inter-disease (coronary vs. valve) differ-
ences in the content of amino acids have also been re-
ported (Suleiman et al. 1998).
Interestingly, there are no studies that simultaneously
compare cardiac amino acids in LV and RV of both cor-
onary artery disease and aortic valve stenosis patients.
We have shown that the two pathologies required differ-
ent cardioplegic interventions to achieve optimal cardio-
protection (Suleiman et al. 2001, 2008, 2011). We now
propose that the design of cardio-protective strategies
should also take into account the fact that the two sides
of the heart are different and may respond differently to
ischemia and reperfusion. To address this point we mea-
sured myocardial amino acids in both LV and RV of
patients with either aortic valve stenosis (AVS) or coron-
ary artery disease (CAD).
Materials and methods
Patients
Adult patients (n = 58) having either elective or urgent iso-
lated coronary artery bypass grafting or aortic valve re-
placement using cardiopulmonary bypass were included in
this study. Exclusions included patients who had under-
gone previous surgery, were having combined coronary
and valve surgery, an emergency or salvage operation, were
already participating in another clinical trial, or those with
chronic renal failure requiring dialysis, current congestive
heart failure or poor left ventricular function.
The investigation conforms to the principles outlined in
the Declaration of Helsinki. Ethical approval by the NHS
Research Ethics Committee (ISRCTN84968882) as well as
patient consent were obtained. Patients with coronary ar-
tery disease (included only 3 female patients) were ana-
lyzed for the effect of type 2 diabetes whilst patients with
aortic valve disease (included only one diabetic patient)
were analyzed for the effect of gender. Patients’ character-
istics are shown in Table 1. There were no significant dif-
ferences in terms of NYHA classification between the
subgroups. The number of female patients with CAD
undergoing surgery (9%) is relatively small compared to
approximately 32% reported by others (Blankstein et al.
Table 1 Patients characteristics
Coronary artery disease
Total
(n = 36)
Diabetics
(n = 13)
Non-diabetic
(n = 23)
Age (years) 67.1 ± 1.3 66.2 ± 2.4 67.6 ± 1.6
Sex (male/female) 33/3 13/0 20/3
NYHA Classification
I 10 5 5
II 16 5 11
III 9 3 6
IV 1 0 1
Aortic Valve Disease
Total (n = 22) Male (n = 10) Female (n = 12)
Age (years) 68.9 ± 2.0 65.0 ± 3.3 72.1 ± 2.0
Diabetes (Yes/No) 1/21 0/10 1/11
NYHA Classification
I 4 2 2
II 7 3 4
III 11 5 6
IV 0 0 0
Data are shown as mean ± SEM. NYHA = New York Heart Association.
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2005). However, CAD females very often present with
other co-morbidities which is in contrast to this study
where surgery was only for isolated CAD. The incidence
of diabetes mellitus in patients undergoing aortic valve
surgery tends to be low and similar for both males and fe-
males at approximately 10% (Higgins et al. 2011).
Collection of ventricular biopsies
Patients were anesthetized in the routine manner used
in our institute, and then cardiopulmonary bypass was
initiated. Immediately following the institution of cardio-
pulmonary bypass, myocardial tissue biopsy specimens
were collected from the apex of LV and RV using a
14 Ga. TW’11.4 cm cannula Trucut needle (Baxter
Healthcare Corporation, USA). Each specimen was im-
mediately snap frozen (less than 5 s) in liquid nitrogen
and stored at -80°C until processing for amino acid ex-
traction and quantification.
Determination of amino acids in biopsy specimens
Free amino acids were measured in all biopsies collected.
Amino acids were determined using HPLC according to
the Pico-Tag method of Water as reported earlier (Caputo
et al. 1998b). In brief, frozen biopsy specimens were
crushed in liquid nitrogen and the resultant powder was ex-
tracted with 4.8% perchloric acid. Neutralized 100 μL of the
extract was dried immediately after extraction using vac-
uum centrifugation (Savant SV160). Free amino acids were
derivatized by phenylisothiocyanate (PITC) and were sepa-
rated by 30 cm Pico-Tag column (Millipore Corporation,
USA) with two Beckman delivery pumps at a constant flow
rate of 1 ml/min with gradient elution for 25 min at 46°C.
Derivatized amino acids were detected at 254 nm using a
Beckman System Gold 166 Detector. Quantitative analysis
was carried out using amino acid standards (Thermo, UK)
and the acquired data were processed using 32 Karat soft-
ware supplied by Beckman. Concentration of metabolites
was expressed as nmol/mg wet weight.
Statistical analysis
Data were expressed as mean ± standard error of the mean
(SEM). Comparison between continuous variables was
made using non-parametric tests for paired or unpaired
samples (tested using Mann–Whitney or Wilcoxon’s
signed rank). All statistical analyses mentioned were per-
formed with the aid of a computerized software package,
Statview for Windows (SAS Institute Inc., NC, USA).
Results
The effect of CAD compared to AVS on levels of amino
acids in LV and RV
There was no difference in the cardiac α-amino acids,
glutamate, glutamine, aspartate, asparagine and alanine
between LV and RV of CAD patients (Figure 1A-B).
However, the β-amino acid taurine was significantly
lower in RV compared to the LV (6.8 ± 0.4 vs. 8.5 ±
0.8 nmol/mg wet weight, p < 0.05). There was no differ-
ence in the protein α-amino acids between the LV and
RV of AVS patients whilst taurine was significantly lower
in the RV compared to the LV (6.8 ± 0.5 vs. 8.9 ±
0.6 nmol/mg wet weight, p < 0.05). Comparison between
CAD and AVS for LV and RV did not show any signifi-
cant difference. However, alanine tended to be higher in
LV and RV of CAD hearts compared to AVS (LV: 3.2 ±
0.2 vs. 2.7 ± 0.3 nmol/mg wet weight and RV: 3.0 ± 0.2
vs. 2.4 ± 0.2 nmol/mg wet weight) (Figure 1B).
Effect of diabetes on levels of amino acids in LV and RV
of patients with CAD
Both taurine and alanine were significantly lower in RV
compared to LV in non-diabetic patients (Taurine: 6.4 ±
0.5 vs. 8.6 ± 1.2 nmol/mg wet weight and alanine: 2.5 ± 0.2
vs. 3.2 ± 0.3 nmol/mg wet weight, p < 0.05) (Figure 2A-B).
In contrast, diabetic patients had similar levels of taurine
and alanine in both LV and RV. The RV of diabetic pa-
tients had significantly higher levels of alanine compared
to RV of non-diabetic patients (3.7 ± 0.5 vs. 2.5 ±
0.2 nmol/mg wet weight, p < 0.05) (Figure 2B). A similar
trend was seen for aspartate and glutamine.
Effect of gender on levels of amino acids in LV and RV of
patients with AVS
Apart from a strong trend for glutamine to be lower in
the LV compared to the RV, there was no difference in
amino acids, including taurine, between LV and RV for
male patients (Figure 3A-B). In contrast taurine, glutam-
ate, aspartate and asparagine were significantly higher in
the LV compared to RV of female patients. Alanine was
higher in both LV and RV of males compared to females
(LV: 3.2 ± 0.5 vs. 2.3 ± 0.3 nmol/mg wet weight and RV:
3.1 ± 0.4 vs. 1.8 ± 0.2 nmol/mg wet weight) (Figure 3B).
Effect of disease, gender and diabetes on metabolic
activity/stress in LV and RV
Figure 4 shows the effect of disease on total α-amino acids
and markers of metabolic stress (ratios of alanine/glutamate
and glutamine/glutamate). Both LV and RV of CAD tended
to show higher evidence of metabolic stress (alanine/glu-
tamate) compared to aortic valve disease (LV: 0.36 ± 0.03
vs. 0.30 ± 0.04 nmol/mg wet weight and RV: 0.38 ± 0.05 vs.
0.30 ± 0.04 nmol/mg wet weight). Furthermore, the glutam-
ine/glutamate ratio was significantly higher in the RV com-
pared to LV of each pathology (Figure 4C).
Figure 5 shows data from CAD comparing the effect
of diabetes. The diabetic RV tended to have bothelevated
total α-amino acids and a higher alanine/glutamate ratio
compared to both diabetic LV and non-diabetic RV. The
diabetic LV had significantly lower glutamine/glutamate
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ratio compared to diabetic RV (0.80 ± 0.10 vs. 1.19 ±
0.14 nmol/mg wet weight, p < 0.05). The diabetic LV had a
significantly lower glutamine/glutamate ratio compared to
non-diabetic LV (0.80 ± 0.10 vs. 1.00 ± 0.06 nmol/mg wet
weight, p < 0.05).
Figure 6 shows the data from male and female patients
with AVS. The total α-amino acids (Figure 6A) were higher
in the LV of female patients compared to other ventricles,
although this was only significant compared to male LV
(27.3 ± 1.7 vs. 21.3 ± 1.7 nmol/mg wet weight, p < 0.05).
The male LV had significantly more metabolic stress/activ-
ity compared to female LV (0.41 ± 0.07 vs. 0.22 ±
0.03 nmol/mg wet weight, p < 0.05) and a trend to increase
in the RV (0.37 ± 0.06 vs. 0.23 ± 0.04 nmol/mg wet weight).
Discussion
To the best of our knowledge, this is the first study that
simultaneously compares the myocardial concentration
of taurine and the principal α-amino acids in LV and RV
of patients with either CAD or AVS. Previous studies
tended to focus on one pathology and/or changes in one
ventricle. In the present study, we show the novel obser-
vations that the LV of either coronary artery disease or
aortic valve disease patients has significantly higher
levels of taurine compared to their respective RV and
that this difference disappears in both diabetic patients
with coronary artery disease and in male patients with
aortic valve disease. Diabetic RV and non-diabetic LV
have more alanine compared to non-diabetic RV. This is
Figure 1 Effect of anatomy and pathology on basal levels of cardiac amino acids. The myocardial concentration of taurine and free
principal α-amino acids (glutamate, glutamine, alanine, aspartate and asparagine) in biopsies collected from both left (LV) and right (RV) ventricles
of hearts of aortic valve stenosis (n = 22) and coronary artery disease (n = 36) patients. Panel (A) shows data for taurine, glutamine and glutamate
while panel (B) shows data for alanine, aspartate and asparagine. Data are shown as mean ± SEM. * = p < 0.05 vs. corresponding left ventricle.
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consistent with stress in diabetic RV as shown by a
higher glutamine/glutamate ratio. The two chambers of
the heart are different in females but not males. The LV
of female patients had significantly more glutamate, as-
partate, asparagine than corresponding right and more
glutamate and glutamine than LV of male patients. This
LVs of female patients have relatively less metabolic
stress as measured by a low alanine/glutamate ratio.
Left ventricle has more taurine than the right ventricle
irrespective of disease state and this difference is
dependent on diabetes and gender
Taurine concentration, measured simultaneously in both
the left and right ventricles of the two cardiac diseases
considered is higher in the left ventricle than in the right
ventricle. The levels and the extent of the differences
were similar for both groups of patients. This suggests
that the left and right ventricles have different taurine
levels irrespective of the disease state. The finding that
taurine is higher in the LV of patients with AVS has
already been reported (Lotto et al. 2003). The LV of
these patients is hypertrophic and the RV is relatively
normal. However, a similar observation has also been
made for patients with mitral valve disease where the LV
is dilated (Venturini et al. 2009). In this work, we show
for the first time that patients with coronary artery dis-
ease also have higher taurine levels in their LV compared
to RV. These hearts, and unlike hearts from patients
with aortic valve disease, do not have a homogeneous
disease-induced global remodeling (e.g. left ventricular
hypertrophy, in the case of aortic valve disease). In pa-
tients with coronary artery disease (significant occlusive
atherosclerosis), the macroscopic effect of disease is in
most cases largely restricted to a small number of ves-
sels. However, the availability of coronary flow reserve
can compensate for the effect of stenosis by way of
Figure 2 Effect of diabetes on basal levels of amino acids in left and right ventricles of coronary artery disease patients. The concentration
of taurine and principal free amino acids (glutamate, glutamine, alanine, aspartate and asparagine) in biopsies collected from both left (LV) and right
(RV) ventricles of diabetic (n = 13) and non-diabetic (n = 23) coronary artery disease patients. Panel (A) shows data for taurine, glutamine and glutamate
while panel (B) shows data for alanine, aspartate and asparagine. Data are shown as mean ± SEM. * = p <0.05.
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vasodilation of the downstream arteriolar resistance ves-
sels which will help to maintain coronary flow in these
areas (Di Carli et al. 1995; Gould 2005; Gould et al. 1975,
2000). Additionally, the biopsies were collected from areas
distal to the stenosis. Therefore, LV with global remodel-
ing (hypertrophy or dilation) appears to be similar to LV
that has localized atherosclerotic disease. What is interest-
ing however, is the finding that a dilated LV secondary to
mitral valve disease has a markedly higher taurine concen-
tration (1.55 fold) compared to right ventricle (Venturini
et al. 2009). In contrast, taurine in the hypertrophic LV
secondary to aortic stenosis is only 1.26–1.32 fold higher
than right ventricle ((Lotto et al. 2003) and Figure 1A).
This is similar or slightly higher than coronary artery dis-
ease patients with 1.25 fold (Figure 1A). This is not
straight forward as our study revealed for the first time
that taurine content in left and right ventricles of patients
with coronary artery disease is dependent on diabetes.
Diabetic patients with coronary artery disease have simi-
lar levels of taurine in both ventricles whereas non-
diabetics have ~1.3 fold more taurine in the LV compared
to the right ventricle. This is largely due to a trend for the
right ventricle of diabetics to have more taurine than the
right ventricle of non-diabetics (Figure 2A). Diabetes and
associated cardiovascular complications have been linked to
changes in plasma and myocardial taurine levels. Diabetes
Figure 3 Effect of gender on basal levels of amino acids in left and RVs of aortic valve stenosis patients. The concentration of taurine
and principal free amino acids (glutamate, glutamine, alanine, aspartate and asparagine) in biopsies collected from both left (LV) and right (RV)
ventricles of male (n = 10) and female (n = 12) aortic valve stenosis patients. Panel (A) shows data for taurine, glutamine and glutamate while
panel (B) shows data for alanine, aspartate and asparagine. Data are shown as mean ± SEM. * = p <0.05.
Lewis et al. SpringerPlus 2014, 3:523 Page 6 of 11
http://www.springerplus.com/content/3/1/523
leads to depletion of intracellular taurine (Hansen 2001)
which appears to be associated with the development of
late diabetic cardiomyopathy (Li et al. 2005). Additionally
diabetic patients have significantly lower plasma taurine
than normal subjects (Franconi et al. 1995). It is not, there-
fore, surprising that dietary supplementation of taurine at-
tenuates diabetes-induced changes in cardiac contractile
function and ultrastructure (Das et al. 2012; Tappia et al.
2011). Interestingly, the depletion of taurine has been
linked to the development of atherosclerosis (Hansen
2001). Since both diabetics and non-diabetics have coron-
ary artery disease, it is likely that the reported diabetes-
induced lower taurine in myocardium is due to diabetic
cardiomyopathy independent of coronary artery disease.
The lower plasma levels in diabetic patients could be a
consequence of tissue accumulation as seen here for the
right ventricle. In the context of taurine having major cel-
lular effects during cardiac insults, this work suggests that
LV of diabetics is likely to show similar vulnerability to re-
perfusion injury compared to non-diabetics. However, the
right ventricle of non-diabetics with low taurine could be
either preconditioned and more resistant to insults (Allo
et al. 1997) or more vulnerable due to less available tau-
rine to help efflux accumulated Na+ and to oppose oxida-
tive stress and apoptotic death (Chapman et al. 1993;
Suleiman et al. 1992) (Parildar et al. 2008; Schaffer et al.
2010, 2014; Takahashi et al. 2003; Takatani et al. 2004a, b).
Interestingly, taurine deficiency, rather than accumulation,
has been implicated in the development of cardiomyop-
athy (Ito et al. 2008) and therefore it can be argued that
taurine accumulation is in fact an adaptation to disease
development. This is supported by an earlier finding in
dogs with congestive heart failure where the severity of
the disease significantly correlated with taurine content
(Newman et al. 1977). It must be stressed however, that
taurine depletion is also associated with adaptation to
pathology as neonatal myocytes depleted of taurine
showed significant changes in shape and size (Schaffer
et al. 1998). Clearly more work is needed to provide an an-
swer to this issue.
Left to right ventricle taurine ratio in female patients
with aortic valve stenosis was ~1.55 which is similar to
patients with mitral valve disease (see above). On the
other hand taurine levels were similar for both left and
right ventricles of male patients (~1.1). The relatively
lower level of taurine in the right ventricle of female pa-
tients with aortic valve stenosis is similar to the finding
Figure 4 The effect of disease on markers of stress in left and RVs.
Total free α-amino acids (A), alanine/glutamate ratio (B) and glutamine/
glutamate ratio (C) in biopsies collected from both left and RVs of hearts
of aortic valve stenosis (n = 22) and coronary artery disease (n = 36)
patients. Data are shown as mean ± SEM. * = p <0.05.
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for non-diabetic right ventricle of coronary artery dis-
ease patients (see above).
Alanine is the only α-amino acid that changes in response
to coronary artery disease and diabetes
There was no intra- or inter-disease differences in any of
the principal α-amino acids (Figure 1). Our earlier find-
ing that the LV of patients with coronary artery disease
had significantly higher alanine levels than patients with
aortic valve stenosis (Suleiman et al. 1998) has not been
confirmed in this study. However, there was a strong
tendency for alanine to be higher in both left and right
ventricles of coronary artery disease hearts compared to
aortic valve disease (Figure 1B). A likely explanation for
this could be the disease intensity which if not severe
could mask the difference as the difference was attrib-
uted to higher ischemic stress due to coronary artery
disease. However, a closer look shows that the trend to
accumulate alanine in the right ventricle appears to be
associated with diabetes (Figure 2B). This is consistent
with stress in diabetic right ventricle as shown by a
higher glutamine/glutamate ratio. Myocardial alanine
levels have been shown to increase in experimental
model of diabetes (Scharff and Wool 1966). Furthermore
cardiac activity of alanine aminotransferase increases in
diabetes (Kazmi and Baquer 1985) and seems to predict
coronary heart disease events (Schindhelm et al. 2007).
In the non-diabetic CAD patients, alanine was signifi-
cantly higher in the LV compared to RV (Figure 2B).
The data suggests this is unlikely to be due ischemic cor-
onary disease as the alanine/glutamate ratio is similar
(Figure 5B). However, although the alanine/glutamate ra-
tio has been used as a marker of anaerobic metabolism
during ischemia, its importance in chronic disease has
not been fully addressed. Key aspects relating to amino
acids ratio(s) is the fact that this ratio will be altered by
changes in individual amino acid transporter(s). Therefore
we can only speculate that diabetes alters the expression/
activity of amino acids transporters and therefore the ra-
tio. The observation that non-diabetic RV also has lower
taurine suggests that the basal levels of both amino acids
(alanine and taurine) in “relatively” normal RV are lower
than corresponding LV. Work to support this suggestion
must come from biopsies obtained from normal heart. In
diabetic RV of CAD patients, aspartate tends to be higher
than non-diabetic RV (Figure 2B). This could partly be
Figure 5 The effect of diabetes in coronary artery disease on
markers of stress in left and RVs. Total free α-amino acids (A),
alanine/glutamate ratio (B) and glutamine/glutamate ratio (C) in biopsies
collected from both left and RVs of diabetic (n = 13) and non-diabetic
(n = 23) coronary artery disease patients. Data are shown as mean ± SEM.
* = p <0.05.
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due to diabetes stimulating the malate-aspartate shuttle
which could improve ATP production (Hadj et al. 2003;
Kazmi et al. 1985).
Female patients with aortic valve stenosis have relatively
low metabolic stress compared to male patients
There was no difference in levels of amino acids between
left and right ventricles in the male patients (Figure 3).
The two chambers of the heart appear to be different in
females but not males. The LV of female patients had
significantly more glutamate, aspartate and asparagine
than corresponding right ventricle, and more glutamate
and glutamine than LV of male patients.
The higher concentration of glutamine in the LV of fe-
male patients will have effects on transport and metabol-
ism (Rennie et al. 1994). Like taurine, it will influence
Na+ levels as a result of the increased Na-glutamine
symport activity. Glutamine is also metabolically active
and acts as a nitrogen donor for the biosynthesis of a
number of compounds such as nucleotides and amino
acids including glutamate (Rennie et al. 2001). Although
glutamate can be used as substrate for energy produc-
tion especially during metabolic stress, it also has strong
antioxidant activity in cardiomyocytes (King et al. 2003;
Williams et al. 2001). Due to its cardio-protective effects,
glutamate has been used to supplement cardioplegia
(Robertson et al. 1984; Rosenkranz et al. 1984, 1986).
The total α-amino acids in the LV of female patients was
higher than in other ventricles, although this was only sig-
nificant compared to male LV. This was associated with
relatively lower metabolic stress/activity compared to male
LV as shown by the alanine/glutamate ratio (Figure 6B).
The higher level of aspartate in LV compared to RV in
female patients with AVS (Figure 3B) could have implica-
tions for coping with hypertrophy (stress) as this amino
acid plays an important role in oxidative phosphorylation
and in improving energy production (Hadj et al. 2003).
Overall, this work suggests that LV of female patients
with aortic valve stenosis are better prepared to cope with
stress compared to the corresponding RV and the LV of
male patients. This is consistent with the suggestion that
females adapt to pressure overload differently from males
and could in part explain the finding that regression of
myocardial hypertrophy after aortic valve replacement is
faster in females (Petrov et al. 2010).
Figure 6 The effect of gender in aortic valve stenosis on
markers of stress in left and RVs. Total free α-amino acids (A),
alanine/glutamate ratio (B) and glutamine/glutamate ratio (C) in
biopsies collected from both left and RVs of male (n = 10) and
female (n = 12) aortic valve stenosis patients. Data are shown as
mean ± SEM. * = p <0.05.
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Implication for myocardial protection during aortic valve
replacement and coronary artery bypass graft surgery
The differences in amino acids between LV and RV could
have implications for the extent of ischemia and reperfu-
sion injury during open heart surgery. This of course will
depend on the pathology and the amino acid in question.
For example higher taurine levels in the LV of CAD non-
diabetics and AVS females compared to corresponding RV
suggests improved ability to cope with Na+ loading and
other cellular changes (e.g. oxidative stress). This is more
complicated when it comes to α-amino acids. Although it
can be argued that higher glutamine, glutamate and aspar-
tate in tissues is also beneficial, higher alanine can be con-
sidered as an indicator of increased vulnerability.
The observed differences between the left and right ven-
tricles of patients with either valve stenosis or coronary ar-
tery disease and between ventricles of the two pathologies
clearly indicate that designing a cardio-protective strategy
should take into account these differences. Myocardial pro-
tection techniques are largely aimed at preventing (re-
ducing) the cellular changes in metabolites and ions.
However, having two different ventricles with two different
starting points would require a more thorough consider-
ation of the formulation of cardioplegia. Diabetes in coron-
ary artery disease and gender in aortic valve stenosis are
important determinants or remodeling in amino acid con-
tent with potential impact on vulnerability to ischemia and
reperfusion injury during open heart surgery.
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